Questions swirl after Trump’s GLP-1 pricing deal announcement

At a White House event Thursday, President Trump announced deals with drug makers Novo Nordisk and Eli Lilly to offer their ...
NBC 7 San Diego

Ozempic maker defends high U.S. price: It's ‘helping' reduce the cost of obesity

The CEO of Novo Nordisk is defending the high cost of Ozempic and Wegovy in America, saying the blockbuster drugs are ultimately saving taxpayers money on obesity-related costs. “If you look at just ...